Stock BGNE BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BeiGene, Ltd.

Equities

BGNE

US07725L1026

Market Closed - Nasdaq
Other stock markets
 01:30:00 14/09/2024 am IST 		5-day change 1st Jan Change
198.49 USD +1.13% Intraday chart for BeiGene, Ltd. +3.75% +10.05%
12/09 Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading MT
11/09 Asian Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BEIGENE, LTD. Stock BeiGene, Ltd.
21.1B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
125B -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
124B
ARGENX SE Stock argenx SE
32.35B -
BIONTECH SE Stock BioNTech SE
29.34B -
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
23.47B - - - - -
  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. Charts BeiGene, Ltd.
  5. Sector Chart
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition